Ironwood [IRWD] vs Zoetis [ZTS] Detailed Stock Comparison

Ironwood Pharmaceuticals Inc.

NASDAQ
Loading...

Zoetis Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Ironwood Pharmaceuticals Inc. wins in 6 metrics, Zoetis Inc. wins in 13 metrics, with 0 ties. Zoetis Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Ironwood Pharmaceuticals Inc. Zoetis Inc. Better
P/E Ratio (TTM) 27.13 19.58 Zoetis Inc.
Price-to-Book Ratio -2.35 15.04 Zoetis Inc.
Debt-to-Equity Ratio -2.28 279.59 Zoetis Inc.
PEG Ratio -0.18 2.81 Zoetis Inc.
EV/EBITDA 8.67 13.96 Ironwood Pharmaceuticals Inc.
Profit Margin (TTM) 8.11% 28.24% Zoetis Inc.
Operating Margin (TTM) 13.74% 34.69% Zoetis Inc.
EBITDA Margin (TTM) 13.74% 34.69% Zoetis Inc.
Return on Equity -9.17% 65.99% Zoetis Inc.
Return on Assets (TTM) 19.85% 15.26% Ironwood Pharmaceuticals Inc.
Free Cash Flow (TTM) $127.01M $2.28B Zoetis Inc.
Dividend Yield N/A 1.21% N/A
1-Year Return 488.71% -51.58% Ironwood Pharmaceuticals Inc.
Price-to-Sales Ratio (TTM) 2.24 5.26 Ironwood Pharmaceuticals Inc.
Enterprise Value $1.05B $56.75B Zoetis Inc.
EV/Revenue Ratio 3.53 6.00 Ironwood Pharmaceuticals Inc.
Gross Profit Margin (TTM) N/A 70.17% N/A
Revenue per Share (TTM) $2 $21 Zoetis Inc.
Earnings per Share (Diluted) $0.15 $6.02 Zoetis Inc.
Beta (Stock Volatility) 0.17 0.97 Ironwood Pharmaceuticals Inc.
Short % of Float 16.61% 4.06% Zoetis Inc.

Ironwood Pharmaceuticals Inc. vs Zoetis Inc. Stock Performance Analysis

Loading Price Chart...

IRWD
ZTS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Ironwood Pharmaceuticals Inc.1.10%12.16%3.07%9.50%2.79%-13.58%
Zoetis Inc.1.51%0.16%3.42%-31.08%-32.94%-36.81%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Ironwood Pharmaceuticals Inc.488.71%-66.76%-68.86%-65.27%-72.43%-62.79%
Zoetis Inc.-51.58%-53.40%-57.08%71.34%156.59%156.59%

Performance & Financial Health Analysis: Ironwood Pharmaceuticals Inc. vs Zoetis Inc.

MetricIRWDZTS
Market Information
Market Cap i$617.99M$49.75B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i1,783,7322,727,710
90 Day Avg. Volume i2,608,5373,835,940
Last Close$3.69$167.10
52 Week Range$0.62 - $5.78$139.70 - $200.33
% from 52W High-36.16%-16.59%
All-Time High$17.76 (Jul 09, 2018)$249.27 (Dec 27, 2021)
% from All-Time High-79.22%-32.96%
Growth Metrics
Quarterly Revenue Growth-0.47%0.03%
Quarterly Earnings Growth-0.47%0.04%
Financial Health
Profit Margin (TTM) i0.08%0.28%
Operating Margin (TTM) i0.14%0.35%
Return on Equity (TTM) i-0.09%0.66%
Debt to Equity (MRQ) i-2.28279.59
Cash & Liquidity
Book Value per Share (MRQ)$-1.61$7.84
Cash per Share (MRQ)$1.32$5.48
Operating Cash Flow (TTM) i$127.04M$2.90B
Levered Free Cash Flow (TTM) i$111.57M$1.79B
Dividends
Last 12-Month Dividend Yield iN/A1.21%
Last 12-Month Dividend iN/A$2.03

Valuation & Enterprise Metrics Analysis: Ironwood Pharmaceuticals Inc. vs Zoetis Inc.

MetricIRWD (Apr 24, 2026)ZTS (Apr 13, 2026)
Price Ratios
P/E Ratio (TTM) i27.1319.58
Forward P/E i2.7915.61
PEG Ratio i-0.182.81
Price to Sales (TTM) i2.245.26
Price to Book (MRQ) i-2.3515.04
Market Capitalization
Market Capitalization i$617.99M$49.75B
Enterprise Value i$1.05B$56.75B
Enterprise Value Metrics
Enterprise to Revenue i3.536.00
Enterprise to EBITDA i8.6713.96
Risk & Other Metrics
Beta i0.170.97
Book Value per Share (MRQ) i$-1.61$7.84

Financial Statements Comparison: Ironwood Pharmaceuticals Inc. vs Zoetis Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricIRWD (2025)ZTS (2025)
Revenue/Sales i296.15M9.47B
Cost of Goods Sold iN/A2.67B
COGS % of Revenue i0.0%28.2%
Gross Profit iN/A6.80B
Gross Margin i0.0%71.8%
Research & Development i95.14M698.00M
Operating Income (EBIT) i118.76M3.60B
Operating Margin i40.1%38.0%
EBITDA i124.91M4.17B
EBITDA Margin i42.2%44.1%
Pre-Tax Income i70.03M3.36B
Pre-Tax Income % of Revenue i23.6%35.5%
Income Tax i46.01M687.00M
Income Tax % of Revenue i15.5%7.3%
Net Income (Profit) i24.02M2.67B
Profit Margin i8.1%28.2%

Balance Sheet & Liquidity Metrics

MetricIRWD (2025)ZTS (2025)
Cash & Equivalents i215.46M2.31B
Total Current Assets i274.18M6.77B
Total Current Assets % of Revenue i92.6%71.5%
Total Current Liabilities i242.22M2.24B
Total Current Liabilities % of Revenue i81.8%23.6%
Long-Term Debt i394.87M9.24B
Long-Term Debt % of Revenue i133.3%97.6%
Total Shareholders Equity i-261.84M3.33B
Retained Earnings i-1.67B13.74B
Retained Earnings % of Revenue i-565.2%145.2%
Property, Plant & Equipment i9.34M288.00M

Cash Flow Statement Comparison

MetricIRWD (2025)ZTS (2025)
Operating Cash Flow i130.69M2.78B
Operating Cash Flow % of Revenue i44.1%29.3%
Capital Expenditures i-34,000N/A
Free Cash Flow i127.01M2.28B
FCF Margin i42.9%24.1%
Debt Repayment i0-1.35B
Common Stock Repurchase iN/A-3.24B

Short Interest & Institutional Ownership Analysis

MetricIRWDZTS
Shares Short i17.90M15.12M
Short Ratio i5.913.60
Short % of Float i16.61%4.06%
Shares Outstanding i163.06M424.93M
Float Shares i125.58M421.29M
% Held by Insiders i3.05%0.15%
% Held by Institutions i92.07%101.50%
% Held by Public i4.88%-1.65%

Dividend Analysis & Yield Comparison: Ironwood Pharmaceuticals Inc. vs Zoetis Inc.

MetricIRWDZTS
Last 12-Month Dividend iN/A$2.03
Last 12-Month Dividend Yield iN/A1.21%
3-Year Avg Annual Dividend iN/A$1.80
3-Year Avg Dividend Yield iN/A0.29%
3-Year Total Dividends iN/A$5.39
Ex-Dividend DateN/AJan 20, 2026